Comparison of hospital resource utilization parameters in patients with nonvalvular atrial fibrillation anticoagulated with rivaroxaban versus warfarin: a retrospective cohort study

被引：0
|
作者：
Jain, Barkha [1 ]
Brunetti, Luigi [2 ]
机构：
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharm Practice & Adm, Piscataway, NJ USA
[2] Robert Wood Johnson Univ Hosp Somerset, Dept Pharm, Somerville, NJ USA
来源：
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
273
引用
收藏
页码：E201 / E201
页数：1
相关论文
共 50 条
  • [1] Rivaroxaban versus Warfarin: Effect on Healthcare Resource Utilization and Costs in Nonvalvular Atrial Fibrillation Patients
    Laliberte, Francois
    Crivera, Concetta
    Nelson, Winnie W.
    Olson, William H.
    Schein, Jeffrey
    Germain, Guillaume
    Lefebvre, Patrick
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 480 - 481
  • [2] The influence of rivaroxaban versus warfarin therapy for stroke prevention in hospital resource utilization in nonvalvular atrial fibrillation patients.
    Jain, Barkha
    Brunetti, Luigi
    [J]. PHARMACOTHERAPY, 2017, 37 (06): : E55 - E55
  • [3] Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study
    Mittal, V. Simon
    Wu, Bingcao
    Song, Ji
    Milentijevic, Dejan
    Ashton, Veronica
    Mahajan, Dheeraj
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 529 - 536
  • [4] Healthcare Resource Utilization and Costs Among Nonvalvular Atrial Fibrillation Patients Initiating Rivaroxaban or Warfarin in Skilled Nursing Facilities: A Retrospective Cohort Study
    Mittal, V. Simon
    Wu, Bingcao
    Song, Ji
    Milentijevic, Dejan
    Ashton, Veronica
    Mahajan, Dheeraj
    [J]. CIRCULATION, 2019, 140
  • [5] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Garg, Jyotsna
    Pan, Guohua
    Singer, Daniel E.
    Hacke, Werner
    Breithardt, Guenter
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Piccini, Jonathan P.
    Becker, Richard C.
    Nessel, Christopher C.
    Paolini, John F.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10): : 883 - 891
  • [6] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
    Pearson, Scott
    Troughton, Richard
    Richards, A. Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2334 - 2335
  • [7] Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
    Matthew R. Weir
    Yen-Wen Chen
    Jinghua He
    Brahim Bookhart
    Alicia Campbell
    Veronica Ashton
    [J]. Diabetes Therapy, 2021, 12 : 3167 - 3186
  • [8] Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
    Weir, Matthew R.
    Chen, Yen-Wen
    He, Jinghua
    Bookhart, Brahim
    Campbell, Alicia
    Ashton, Veronica
    [J]. DIABETES THERAPY, 2021, 12 (12) : 3167 - 3186
  • [9] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY
    Patel, Manesh R.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2335 - 2335
  • [10] RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 338 - 338
12345